about
HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCCEvaluation of a deformable registration algorithm for subsequent lung computed tomography imaging during radiochemotherapy.Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium RadHPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology GLow Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy
P50
Q36204937-3DA2944B-D390-4C38-ACBA-1999A1B65125Q39430094-71A49859-37E3-4504-B728-0442FD016C1EQ39727939-6AF6CB0A-D680-4100-BD03-81700F899B6DQ39923997-6FD300FB-AFEC-4542-AF8B-DE912CB96085Q40476063-2D3788E4-2B72-44A6-97BE-C6A51C696058Q40732246-D6D8FD72-4F79-449A-B72B-1455CFFAB5F4Q40784146-A8D018DF-EC7A-4C37-87FD-7F8C4A0DD82AQ42014057-E029F369-02B2-4AE2-9943-F3F3022F401FQ42177534-620BB55C-49FA-4C5F-B418-8AE1DB214C20Q50912757-5C2BDD73-1D57-4493-936E-DAB6D52ACF44Q86191806-87323621-FC96-4770-A280-4A2E20C6688A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4043-7066
@en
name
Fabian Lohaus
@ast
Fabian Lohaus
@en
Fabian Lohaus
@es
Fabian Lohaus
@nl
type
label
Fabian Lohaus
@ast
Fabian Lohaus
@en
Fabian Lohaus
@es
Fabian Lohaus
@nl
prefLabel
Fabian Lohaus
@ast
Fabian Lohaus
@en
Fabian Lohaus
@es
Fabian Lohaus
@nl
P106
P108
P21
P31
P496
0000-0003-4043-7066